GlassScriptPhysician profile
Erin Suvar
NPI 1790324390
$4,306.05
in general payments reported to CMS, 2019-2025
12 companies · $2,393 in 2025
The $2,393 reported for 2025 was more than what 96% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $414 · 2023: $594 · 2024: $905 · 2025: $2,393.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,669 · Consulting Fee: $605 · Honoraria: $300 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $225 · Education: $92.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,669.36 |
| Consulting Fee | $605.00 |
| Honoraria | $300.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $225.00 |
| Education | $92.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $976.75 | 2023-2025 | |
| Genzyme Corporation | $811.47 | 2022-2025 | |
| Chiesi USA, INC. | $730.00 | 2025 | Ferriprox |
| Daiichi Sankyo INC. | $407.38 | 2022-2024 | Enhertu, Injectafer |
| Alexion Pharmaceuticals, INC. | $373.83 | 2022-2025 | Ultomiris |
| Pfizer INC. | $250.00 | 2025 | |
| Beone Medicines USA, INC. | $150.00 | 2025 | Brukinsa |
| Sobi, INC | $139.99 | 2023-2025 | |
| Glaxosmithkline, LLC. | $125.00 | 2025 | Jemperli |
| Amgen INC. | $124.97 | 2025 | Blincyto |
| Agios Pharmaceuticals, INC. | $123.67 | 2023 | Pyrukynd |
| Incyte Corporation | $92.99 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Suvar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.